ArticleTheranostics2020
CNTNAP4 deficiency in dopaminergic neurons initiates parkinsonian phenotypes.
Open access · goldAbstract read
In one paragraph
Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.
0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 12% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.
- Extended genome-wide association study employing the African genome resources panel identifies novel susceptibility loci for Alzheimer's disease in individuals of African ancestry.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024Pooled it
- Heparan Sulfate Proteoglycans: Master Regulators of Cellular Signaling, Tissue Development, and Neural Function.Journal of neuroscience research · 2026Review
- ATP6V0A1 protects dopaminergic neurons via the autophagy-lysosomal pathway in Parkinson's disease.Neural regeneration research · 2026Article
- Histone H3 lysine 9 tri-methylation is associated with pterygium.BMC ophthalmology · 2025Article
- Impact of LITAF on Mitophagy and Neuronal Damage in Epilepsy via MCL-1 Ubiquitination.CNS neuroscience & therapeutics · 2025Article
- nlr-1/CNTNAP regulates dopamine circuit structure and foraging behaviors in C. elegans.Communications biology · 2024Article
- CHCHD2 Thr61Ile mutation impairs F1F0-ATPase assembly inNeural regeneration research · 2024Article
- Neural EGFL-like 1, a craniosynostosis-related osteochondrogenic molecule, strikingly associates with neurodevelopmental pathologies.Cell & bioscience · 2023Article
- Microglial targeted therapy relieves cognitive impairment caused byExploration (Beijing, China) · 2023Article
- Dietary intake of α-ketoglutarate ameliorates α-synuclein pathology in mouse models of Parkinson's disease.Cellular and molecular life sciences : CMLS · 2023Article
- Cntnap4 partial deficiency exacerbates α-synuclein pathology through astrocyte-microglia C3-C3aR pathway.Cell death & disease · 2023Article
- Antiseizure Properties of Histamine HMolecules (Basel, Switzerland) · 2023Article
- Biomimetic Remodeling of Microglial Riboflavin Metabolism Ameliorates Cognitive Impairment by Modulating Neuroinflammation.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023Article
- Article
- Genetic modifiers of synucleinopathies-lessons from experimental models.Oxford open neuroscience · 2023Review
- Functional investigation of SLC1A2 variants associated with epilepsy.Cell death & disease · 2022Article
- Comparison of the effect of rotenone and 1‑methyl‑4‑phenyl‑1,2,3,6‑tetrahydropyridine on inducing chronic Parkinson's disease in mouse models.Molecular medicine reports · 2022Article
- Trojan Horse Delivery of 4,4'-Dimethoxychalcone for Parkinsonian Neuroprotection.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021Article
- Functional validation of a human GLUD2 variant in a murine model of Parkinson's disease.Cell death & disease · 2020Article
- Circulating metabolomics profiling reveals novel pathways associated with cognitive decline in patients with hypertension.Therapeutic advances in neurological disorders · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 4 institutions in 1 country.
Wenlong ZhangDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Miaomiao ZhouDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Weiye LuKey Laboratory of Neurological Function and Health, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Junwei GongKey Laboratory of Neurological Function and Health, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Feng GaoKey Laboratory of Neurological Function and Health, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Yuanquan LiKey Laboratory of Neurological Function and Health, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Xuandong XuInformation center of Guangzhou Power Supply Bureau Co., Ltd., Guangzhou 510620, China.
Yuwan LinDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xiaokang ZhangThe First Affiliated Hospital of Gannan Medical University, Ganzhou, Jiangxi, China.
Liuyan DingDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Zhiling ZhangDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Guihua LiDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xiang ChenDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Xiangdong SunSchool of Basic Medical Sciences, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China.
Xiaoqin ZhuSchool of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Pingyi XuDepartment of Neurology, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510120, China.
Yunlong ZhangKey Laboratory of Neurological Function and Health, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China.
Guangzhou Medical University · CNFirst Affiliated Hospital of Guangzhou Medical University · CNFirst Affiliated Hospital of Gannan Medical University · CNXiamen University · CN
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
alpha-SynucleinAnimalsCell LineDopaminergic NeuronsFemaleGene Knockdown TechniquesHumansMaleMembrane Potential, MitochondrialMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutMitophagyNerve Tissue ProteinsParkinson Diseasealpha-SynucleinCNTNAP4 protein, humanCntnap4 protein, mouseMembrane ProteinsNerve Tissue ProteinsRNA, MessengerRNA, Small InterferingSynapsinsCNTNAP4dopaminergic neuronsmitophagyParkinson's diseaseα-synuclein
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.